| Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 KL Ong, LK Stafford, SA McLaughlin, EJ Boyko, SE Vollset, AE Smith, ... The Lancet 402 (10397), 203-234, 2023 | 947 | 2023 |
| Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019 KS Ikuta, LR Swetschinski, GR Aguilar, F Sharara, T Mestrovic, AP Gray, ... The Lancet 400 (10369), 2221-2248, 2022 | 832 | 2022 |
| Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019 HH Kyu, A Vongpradith, SB Sirota, A Novotney, CE Troeger, MC Doxey, ... The Lancet Infectious Diseases 22 (11), 1626-1647, 2022 | 125 | 2022 |
| Bedaquiline: Current status and future perspectives S Khoshnood, M Goudarzi, E Taki, A Darbandi, E Kouhsari, M Heidary, ... Journal of global antimicrobial resistance 25, 48-59, 2021 | 67 | 2021 |
| Mechanism of action, resistance, synergism, and clinical implications of azithromycin M Heidary, A Ebrahimi Samangani, A Kargari, A Kiani Nejad, I Yashmi, ... Journal of clinical laboratory analysis 36 (6), e24427, 2022 | 49 | 2022 |
| Mechanism of Action, Resistance, Synergism, and Clinical Implications of Delamanid Against Multidrug-Resistant Mycobacterium tuberculosis S Khoshnood, E Taki, N Sadeghifard, KV Hassan, MH Haddadi, ... Frontiers in Microbiology 12, 2021 | 43 | 2021 |
| Prevalence of metallo-β-lactamase-encoding genes among carbapenem-resistant Pseudomonas aeruginosa strains isolated from burn patients in Iran F Jabalameli, E Taki, M Emaneini, R Beigverdi Revista da Sociedade Brasileira de Medicina Tropical 51 (03), 270-276, 2018 | 43 | 2018 |
| Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 HY Wunrow, RG Bender, A Vongpradith, SB Sirota, LR Swetschinski, ... The Lancet Neurology 22 (8), 685-711, 2023 | 38 | 2023 |
| The prevalence of aminoglycoside-modifying enzyme genes among Pseudomonas aeruginosa strains isolated from burn patients M Kashfi, A Hashemi, G Eslami, MS Amin, S Tarashi, E Taki Archives of Clinical Infectious Diseases 12 (1), 2017 | 33 | 2017 |
| Evaluation of genetic pattern and determination of oqxA gene expression levels among clinical isolates of Klebsiella pneumoniae strains A Hashemi, F Fallah, A Taherpour, H Goudarzi, S Erfanimanesh, E Taki Journal of Mazandaran University of Medical Sciences 24 (119), 48-61, 2014 | 22 | 2014 |
| Cabotegravir/Rilpivirine: the last FDA-approved drug to treat HIV E Taki, F Soleimani, A Asadi, H Ghahramanpour, A Namvar, M Heidary Expert Review of Anti-infective Therapy 20 (8), 1135-1147, 2022 | 21 | 2022 |
| Efficacy of methanolic extract of green and black teas against extended-spectrum beta-Lactamase-producing Pseudomonas aeruginosa A Taherpour, A Hashemi, S Erfanimanesh, E Taki Pak J Pharm Sci 29 (4), 1257-61, 2016 | 13 | 2016 |
| Ebanga™: The most recent FDA-approved drug for treating Ebola E Taki, R Ghanavati, T Navidifar, S Dashtbin, M Heidary, M Moghadamnia Frontiers in Pharmacology 14, 1083429, 2023 | 11 | 2023 |
| Detection of blaIMP, blaVIM and OprD genes among Pseudomonas aeruginosa isolated from burn patients M Sadredinamin, A Hashemi, H Goudarzi, S Tarashi, ... Journal of Mazandaran University of Medical Sciences 26 (138), 181-186, 2016 | 8 | 2016 |
| Evaluation of Zenian and Avishan-e Shirazi antibacterial activity against Vibrio cholerae strains A Taherpour, A Hashemi, F Fallah, S Erfani-Manesh, E Taki Journal of Medical Bacteriology 3 (1-2), 17-21, 2014 | 6 | 2014 |
| Prevalence of colistin resistance in clinical isolates of Acinetobacter baumannii: a systematic review and meta-analysis N Bostanghadiri, N Narimisa, M Mirshekar, L Dadgar-Zankbar, E Taki, ... Antimicrobial Resistance & Infection Control 13 (1), 24, 2024 | 5 | 2024 |
| Molecular Characteristics of Staphylococcus aureus Strains Isolated from Nasal Cavity and Wound Infections Among Diabetic Patients E Taki, F Jabalameli, MRM Tehrani, MM Feizabadi, S Halimi, M Sanjari, ... Current Microbiology 80 (5), 147, 2023 | 5 | 2023 |
| Microbial profile and antibiotic susceptibility pattern in diabetic patients with mild, moderate, and severe foot infections in Tehran E Taki, F Jabalameli, R Beigverdi, M Emaneini Archives of Razi Institute 77 (5), 1925, 2022 | 4 | 2022 |
| Evaluation of carbonyl cyanide 3-chlorophenyl hydrazone effect and efflux pump expression level of mexCD-oprJ among Pseudomonas aeruginosa strains isolated from hospitalized … S Tarashi, H Goudarzi, A Hashemi, N Yousefi Nojokambri, ... Journal of Advances in Medical and Biomedical Research 25 (108), 43-55, 2017 | 2 | 2017 |
| In vitro evaluation of capsaicin inhibitory effects on zonula occludens toxin in vibrio cholerae ATCC14035 strain S Erfanimanesh, G Eslami, H Goudarzi, A Taherpour, A Hashemi, E Taki Research in Molecular Medicine 2 (4), 33-35, 2014 | 2 | 2014 |
